BRIEF published on 11/24/2025 at 15:11, 9 months 17 days ago Le groupe Vanguard, Inc. révèle sa position dans Mural Oncology plc Actionnariat Groupe Vanguard Divulgation Oncologie Murale Panel Irlandais Des OPA
BRIEF published on 11/24/2025 at 15:10, 9 months 17 days ago Newmark Group Strengthens Presence in France with Strategic Acquisition Mergers & Acquisitions Real Estate Advisory France Expansion Newmark Group Valuation Services
BRIEF published on 11/24/2025 at 15:10, 9 months 17 days ago Le groupe Newmark renforce sa présence en France grâce à une acquisition stratégique Fusions Et Acquisitions Conseil En Immobilier Expansion En France Groupe Newmark Services D'évaluation
BRIEF published on 11/24/2025 at 15:09, 9 months 17 days ago Heidelberg Pharma Appoints New CEO Amidst Executive Changes Executive Changes Biotech Industry Heidelberg Pharma ADCs Dr. Dongzhou Liu
BRIEF published on 11/24/2025 at 15:09, 9 months 17 days ago Heidelberg Pharma nomme un nouveau PDG dans un contexte de changements au sein de sa direction Heidelberg Pharma Industrie Biotechnologique Changements Exécutifs Dr Dongzhou Liu CAN
BRIEF published on 11/24/2025 at 15:05, 9 months 17 days ago Eleving Group Announces 2026 Financial Calendar Financial Calendar Fintech Unaudited Results Eleving Group 2026
BRIEF published on 11/24/2025 at 15:05, 9 months 17 days ago Eleving Group annonce son calendrier financier pour 2026 Calendrier Financier Fintech Groupe D'élévation Résultats Non Audités 2026
BRIEF published on 11/24/2025 at 15:05, 9 months 17 days ago Jaguar Health Strengthens IP with New Patent for Crofelemer in Intestinal Disorders Crofelemer Patent Clinical Trials Jaguar Health Intestinal Disorders
BRIEF published on 11/24/2025 at 15:05, 9 months 17 days ago Jaguar Health renforce sa propriété intellectuelle grâce à un nouveau brevet pour le crofélémère dans le traitement des troubles intestinaux. Crofelemer Jaguar Health Essais Cliniques Brevet Troubles Intestinaux
BRIEF published on 11/24/2025 at 14:50, 9 months 17 days ago Freedom Bank Revolutionizes Banking with AI Integration Digital Transformation GovTech Super App AI Banking Investment Currency
Published on 09/11/2026 at 21:25, 1 hour 37 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 6 hours 2 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 6 hours 2 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 7 hours 37 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 22:15, 47 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 52 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 3 hours 17 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 4 hours 47 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 16 hours 2 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 16 hours 2 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 16 hours 2 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 3 hours ago Availability of the 2026 Interim Financial Report
